Miguel Tejada was also linked to Biogenesis

11 Comments

Royals infielder Miguel Tejada was handed a 105-game suspension from MLB over the weekend following multiple positive tests for amphetamine use, but Pedro Gomez of ESPN.com reports that the former American League MVP was also implicated in the recent Biogenesis investigation. In fact, it appears MLB leveraged his link to Biogenesis to get him to drop an appeal on his 105-game suspension.

Major League Baseball had the choice of going after the 2002 American League MVP for the Biogenesis case, as the league did 13 other players earlier this month, or for the amphetamine case. MLB chose to suspend Tejada after he tested positive for a third time in his career for amphetamines.

Tejada, according to a source familiar with the case, was given the choice of either accepting the 105-game suspension for amphetamine use or facing additional punishment for his Biogenesis connection. Tejada was allegedly a customer of Tony Bosch’s shuttered clinic, which is at the heart of baseball’s recent rash of suspensions. Bosch supplied evidence that Tejada had been a Biogenesis customer.

Tejada has been linked to performance-enhancing drugs dating back to the Mitchell Report and plead guilty to misleading Congress back in 2009. He admitted to purchasing human growth hormone (HGH) in the past, but claimed that he threw the drugs away before injecting them. It’s not clear what he may have purchased from Biogenesis, but any denials are going to ring pretty hollow at this point.

The Royals recently moved Tejada to the 60-day disabled list following a calf strain, so his season was essentially over anyway, but the suspension will also knock him out of commission for the first 64 games in 2014. The 39-year-old has insisted that he doesn’t plan to retire, but there’s a real chance that we have seen the last of him in the majors.

Report: Royals sign Neftali Feliz

Andy Lyons/Getty Images
1 Comment

Ken Rosenthal of FOX Sports reports that the Royals have signed free agent reliever Neftali Feliz, pending a physical. The Brewers designated Feliz for assignment last week and released him on Monday.

Feliz, 29, opened the season as the Brewers’ closer, but struggled and was eventually taken out of the role in mid-May, giving way to Corey Knebel. In 29 appearances spanning 27 innings with the Brewers, Feliz posted a 6.00 ERA with a 21/15 K/BB ratio.

The Royals have had bullpen issues of their own, so Feliz will try to provide some stability given his track record. It’s not clear yet if the Royals want to let Feliz get his feet wet at Triple-A or throw him right into the bullpen mix.

Mets may move Asdrubal Cabrera to second base upon return from DL

Mike Zarrilli/Getty Images
1 Comment

Newsday’s Marc Carig reports that the Mets may move Asdrubal Cabrera to second base when he returns from the disabled list. Cabrera has been on the disabled list since June 13 with a sprained left thumb, but he’s expected to be activated on Friday.

Cabrera, 31, last played second base in 2014 with the Nationals. He has played shortstop exclusively as a Met the last two seasons. Jose Reyes would continue to play shortstop if the Mets were to go through with the position change. Cabrera would displace T.J. Rivera, who has been playing second base in place of the injured Neil Walker.

In 196 plate appearances this season, Cabrera is hitting .244/.321/.392 with six home runs and 20 RBI. He has made 11 defensive errors, which is tied for the third-most among shortstops behind Tim Anderson (16) and Dansby Swanson (12).